Long-term outcome of an HIV-treatment programme in Rural Africa: Viral suppression despite early mortality

AIDS Research and Treatment

Volumn 2011, Issue , 2011, Pages

  Barth, Roos E ^a   Tempelman, Hugo A ^b   Moraba, Robert ^b   Hoepelman, Andy I M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Ndlovu Medical Centre   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79959356143     PISSN: 20901240     EISSN: 20901259     Source Type: Journal    
DOI: 10.1155/2011/434375     Document Type: Article

References (20)

1. Rosen S., Fox M. P., Gill C. J., Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Medicine 2007 4 10, article e298 1691 1701 2-s2.0-35649003880 10.1371/journal.pmed.0040298 (Pubitemid 350035458)
2. Barth R. E., r.e.barth@umcutrecht.nl van der Loeff M. F. S., Schuurman R., Hoepelman A. I., Wensing A. M., Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review. The Lancet Infectious Diseases 2010 10 3 155 166 10.1016/S1473-3099(09)70328-7
3. Bisson G. P., Gross R., Strom J. B., Rollins C., Bellamy S., Weinstein R., Friedman H., Dickinson D., Frank I., Strom B. L., Gaolathe T., Ndwapi N., Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy. AIDS 2006 20 12 1613 1619 2-s2.0-33746780699 10.1097/01.aids.0000238407.00874.dc (Pubitemid 44162403)
4. Kantor R., Diero L., Delong A., Kamle L., Muyonga S., Mambo F., Walumbe E., Emonyi W., Chan P., Carter J. E., Hogan J., Buziba N., Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings. Clinical Infectious Diseases 2009 49 3 454 462 2-s2.0-67651085129 10.1086/600396
5. van Oosterhout J. J. G., Brown L., Weigel R., Kumwenda J. J., Mzinganjira D., Saukila N., Mhango B., Hartung T., Phiri S., Hosseinipour M. C., Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria. Tropical Medicine and International Health 2009 14 8 856 861 2-s2.0-68949132651 10.1111/j.1365-3156.2009.02309.x
6. Keiser O., okeiser@ispm.unibe.ch Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring. AIDS 2009 23 14 1867 1874 10.1097/QAD.0b013e32832e05b2
7. Barth R. E., van der Meer J. T. M., Hoepelman A. I. M., Schrooders P. A., van de Vijver D. A., Geelen S. P. M., Tempelman H. A., Effectiveness of highly active antiretroviral therapy administered by general practitioners in rural South Africa. European Journal of Clinical Microbiology and Infectious Diseases 2008 27 10 977 984 2-s2.0-53549121685 10.1007/s10096-008-0534-2
8. WHO, Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach, 2006, http://www.who.int/hiv/pub/ guidelines/artadultguidelines.pdf
9. Boulle A., Bock P., Osler M., Cohen K., Channing L., Hilderbrand K., Mothibi E., Zweigenthal V., Slingers N., Cloete K., Abdullah F., Antiretroviral therapy and early mortality in South Africa. Bulletin of the World Health Organization 2008 86 9 678 687 2-s2.0-50849096720 10.2471/BLT.07.045294
10. Collazos J., Asensi V., Cartón J. A., Sex differences in the clinical, immunological and virological parameters of HIV-infected patients treated with HAART. AIDS 2007 21 7 835 843 2-s2.0-34147186323 10.1097/QAD.0b013e3280b0774a (Pubitemid 46573155)
11. Chen S. C., Yu J. K.-L., Harries A. D., Bong C.-N., Kolola-Dzimadzi R., Tok T.-S., King C.-C., Wang J.-D., Increased mortality of male adults with AIDS related to poor compliance to antiretroviral therapy in Malawi. Tropical Medicine and International Health 2008 13 4 513 519 2-s2.0-42149089999 10.1111/j.1365-3156.2008.02029.x (Pubitemid 351533602)
12. Seyler C., Anglaret X., Dakoury-Dogbo N., Messou E., Touré S., Danel C., Diakité N., Daudié A., Inwoley A., Maurice C., Tonwe-Gold B., Rouet F., N'Dri-Yoman T., Salamon R., Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Côte d'Ivoire. Antiviral Therapy 2003 8 5 385 393 2-s2.0-10744233722 (Pubitemid 37351556)
13. Nicastri E., Leone S., Angeletti C., Palmisano L., Sarmati L., Chiesi A., Geraci A., Vella S., Narciso P., Corpolongo A., Andreoni M., Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review. Journal of Antimicrobial Chemotherapy 2007 60 4 724 732 2-s2.0-34548818164 10.1093/jac/dkm302 (Pubitemid 47439674)
14. Kumarasamy N., Madhavan V., Venkatesh K. K., Saravanan S., Kantor R., Balakrishnan P., Devaleenal B., Poongulali S., Yepthomi T., Solomon S., Mayer K. H., Benson C., Schooley R., High frequency of clinically significant mutations after first-line generic highly active antiretroviral therapy failure: implications for second-line options in resource-limited settings. Clinical Infectious Diseases 2009 49 2 306 309 2-s2.0-67651083232 10.1086/600044
15. Soria A., Porten K., Fampou-Toundji J.-C., Galli L., Mougnutou R., Buard V., Kfutwah A., Vessière A., Roussert D., Teck R., Calmy A., Ciaffi L., Lazzarin A., Gianotti N., Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-1infected patients. Antiviral Therapy 2009 14 3 339 347 2-s2.0-67649188417
16. Cozzi-Lepri A., Phillips A. N., Martinez-Picado J., Monforte A. D., Katlama C., Hansen A.-B. E., Horban A., Bruun J., Clotet B., Lundgren J. D., Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings. Journal of Infectious Diseases 2009 200 5 687 697 2-s2.0-70349303657 10.1086/604731
17. Bartlett J. A., Shao J. F., Successes, challenges, and limitations of current antiretroviral therapy in low-income and middle-income countries. The Lancet Infectious Diseases 2009 9 10 637 649 2-s2.0-70349245594 10.1016/S1473-3099(09)70227-0
18. Laurent C., Gueye N. F. N., Ndour C. T., Gueye P. M., Diouf M., Diakhaté N., Kane N. C. T., Lanièce I., Ndir A., Vergne L., Ndoye I., Mboup S., Sow P. S., Delaporte E., Long-term benefits of highly active antiretroviral therapy in senegalese HIV-1-infected adults. Journal of Acquired Immune Deficiency Syndromes 2005 38 1 14 17 2-s2.0-19944427813 10.1097/00126334-200501010-00003 (Pubitemid 40094112)
19. Kouanfack C., Montavon C., Laurent C., Aghokeng A., Kenfack A., Bourgeois A., Koulla-Shiro S., Mpoudi-Ngole E., Peeters M., Delaporte E., Low levels of antiretroviral-resistant HIV infection in a routine clinic in cameroon that uses the World Health Organization (WHO) public health approach to monitor antiretroviral treatment and adequacy with the WHO recommendation for second-line treatment. Clinical Infectious Diseases 2009 48 9 1318 1322 2-s2.0-65549128209 10.1086/597779
20. Walker A. S., s.walker@ctu.mrc.ac.uk Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in Africa. AIDS 2006 20 10 1391 1399 10.1097/01.aids.0000233572.59522.45 (Pubitemid 43948245)